(DSFIR) DSM-Firmenich - Ratings and Ratios
Exchange: AS • Country: Switzerland • Currency: EUR • Type: Common Stock • ISIN: CH1216478797
DSFIR: Flavors, Fragrances, Vitamins, Minerals, Enzymes, Probiotics
DSM-Firmenich AG is a global leader in nutrition, health, and beauty, operating across Switzerland, the Netherlands, Europe, the Middle East, Africa, North America, Latin America, China, and Asia. The company is structured into four key segments: Perfumery & Beauty, Taste, Texture & Health, Health, Nutrition & Care, and Animal Nutrition & Health.
The Perfumery & Beauty segment specializes in creating scents using natural, synthetic, and biotech ingredients, catering to the fragrance needs of global beauty and personal care brands. This segment is a major player in the perfume and fragrance industry, leveraging cutting-edge technology to create unique and sustainable scent solutions.
The Taste, Texture & Health segment focuses on food and beverage solutions, offering a wide range of products including natural flavorings, sugar reduction solutions, and food enzymes. This segment is critical for food manufacturers looking to enhance taste, improve texture, and meet growing consumer demand for healthier and more sustainable food options.
The Animal Nutrition & Health segment provides innovative solutions for the animal production industry, including high-quality animal proteins, performance-enhancing feed additives, and data-driven precision services. This segment is vital for ensuring the health and productivity of livestock, poultry, and aquaculture, with a strong emphasis on sustainability and animal welfare.
The Health, Nutrition & Care segment delivers solutions for early life nutrition, dietary supplements, pharmaceuticals, and biomedical materials. This segment offers a diverse portfolio of products, including vitamins, nutritional lipids, minerals, carotenoids, and probiotics, as well as premix solutions and personalized nutrition offerings. It also provides regulatory affairs and formulation expertise, making it a one-stop-shop for companies in the health and nutrition space.
Founded in 1902 and headquartered in Kaiseraugst, Switzerland, DSM-Firmenich AG has a long history of innovation and leadership in its industries. The company is well-positioned to capitalize on growing trends in health, wellness, and sustainability, making it an attractive investment opportunity for investors looking for exposure to these sectors.
From an investment perspective, DSM-Firmenich AG offers a unique combination of stability, growth potential, and innovation. With a market capitalization of 27,798.18M EUR and a forward P/E ratio of 21.60, the company is valued at a premium, reflecting its strong market position and growth prospects. The P/S ratio of 2.10 indicates a reasonable valuation relative to its revenue, while the P/B ratio of 1.20 suggests that the company’s assets are being valued at a modest premium to their book value.
For investors and fund managers, DSM-Firmenich AG represents a compelling opportunity to invest in a company with a diversified portfolio of businesses, a strong track record of innovation, and a commitment to sustainability. The company’s exposure to fast-growing markets in health, nutrition, and beauty, combined with its leadership in animal nutrition and perfume technologies, makes it a well-rounded investment proposition with significant upside potential.
Ticker Symbol: DSFIR
Exchange: AS
Additional Sources for DSFIR Stock
DSFIR Stock Overview
Market Cap in USD | 30,119m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Personal Care Products |
IPO / Inception |
DSFIR Stock Ratings
Growth 5y | -20.0% |
Fundamental | -29.5% |
Dividend | 57.6% |
Rel. Strength Industry | -17.2 |
Analysts | - |
Fair Price Momentum | 83.22 EUR |
Fair Price DCF | 49.78 EUR |
DSFIR Dividends
Dividend Yield 12m | 2.62% |
Yield on Cost 5y | 2.29% |
Annual Growth 5y | 25.00% |
Payout Consistency | 100.0% |
DSFIR Growth Ratios
Growth Correlation 3m | 15.6% |
Growth Correlation 12m | -21.9% |
Growth Correlation 5y | 43.9% |
CAGR 5y | -9.40% |
CAGR/Max DD 5y | -0.26 |
Sharpe Ratio 12m | -1.62 |
Alpha | -14.93 |
Beta | 0.47 |
Volatility | 28.98% |
Current Volume | 500.7k |
Average Volume 20d | 516.6k |
As of March 12, 2025, the stock is trading at EUR 93.46 with a total of 500,736 shares traded.
Over the past week, the price has changed by -8.64%, over one month by -7.00%, over three months by -11.03% and over the past year by -8.26%.
Probably not. Based on ValueRay Fundamental Analyses, DSM-Firmenich (AS:DSFIR) is currently (March 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -29.52 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DSFIR as of March 2025 is 83.22. This means that DSFIR is currently overvalued and has a potential downside of -10.96%.
DSM-Firmenich has no consensus analysts rating.
According to ValueRays Forecast Model, DSFIR DSM-Firmenich will be worth about 91.1 in March 2026. The stock is currently trading at 93.46. This means that the stock has a potential downside of -2.5%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 132.2 | 41.5% |
Analysts Target Price | - | - |
ValueRay Target Price | 91.1 | -2.5% |